Stibbe’s IP and life sciences practice works closely with its competition, IT and public law teams to guide clients through complex regulatory, compliance and litigation matters. Co-head Ignace Vernimme brings extensive experience across IP, health products and high-stakes disputes, while co-head Philippe Campolini advises Belgian and international clients on IP and life sciences issues, particularly in the medical devices sector.
Legal 500 Editorial commentary
Key clients
- Mylan
- Lifescan
- CSL Behring
- Palex Medical
- European Pharmaceutical Distribution Center
Work highlights
Assisted Sanofi on its equity investment (series D) in Agomab NV. French multinational pharmaceutical company Sanofi, together with equity investor Invus, and other existing shareholders invested 89 million dollar.
Assist Mylan, a global leader in generic and biosimilar pharmaceutical products, in proceedings before the Court of justice of the EU against the European Commission in relation to an exemption granted to one of its competitors on the market exclusivity of its product Tobi Podhaler as an orphan medicinal product. (containing the active substance “tobramycin”
Advised PSG Equity on the acquisition of a stake in the Corilus group, a leader in medical software solutions for the primary care market in Belgium. The transaction also consisted of a re-investment by Rivean Capital, following which both PSG Equity and Rivean Capital have become joint partners to support Corilus’ next stage of growth.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Ignace Vernimme; Philippe Campolini
Other key lawyers
Louis Bidaine